ACTN4 |
5.47 |
0.001 |
Actinin, α 4 |
AXL |
7.04 |
0.0007 |
AXL receptor tyrosine kinase |
BTG1 |
0.49 |
0.0009 |
B-cell translocation gene 1, antiproliferative |
CDC25B |
0.51 |
0.001 |
Cell division cycle 25B |
EEF1A2 |
0.28 |
0.0008 |
Eukaryotic translation elongation factor 1 α 2 |
ERCC1 |
5.23 |
1.04E-05 |
Excision repair cross-complementing rodent repair deficiency, complementation group 1 |
ERCC2 |
2.85 |
0.003 |
Excision repair cross-complementing rodent repair deficiency, complementation group 2 |
ERF |
3.72 |
1.40E-05 |
Ets2 repressor factor |
FN1 |
0.27 |
0.002 |
Fibronectin 1 |
GARS |
5.26 |
0.002 |
Glycyl-tRNA synthetase |
GDI2 |
0.29 |
0.001 |
GDP dissociation inhibitor 2 |
GPR126 |
0.43 |
0.0001 |
G protein–coupled receptor 126 |
IGFBP6 |
17.25 |
0.0004 |
Insulin-like growth factor binding protein 6 |
PRAME |
0.28 |
0.0002 |
Preferentially expressed antigen in melanoma |
PRKAR1A |
0.19 |
8.78E-05 |
Protein kinase, cAMP-dependent, regulatory, type I, α (tissue-specific extinguisher 1) |
PSMB6 |
0.31 |
0.0002 |
Proteasome (prosome, macropain) subunit, β type, 6 |
RAB31 |
0.22 |
0.001 |
RAB31, RAS oncogene family member |
RELB |
4.77 |
3.82E-05 |
v-Rel |
SRPX |
0.37 |
0.0009 |
Sushi repeat–containing protein, X-linked |